Akoya Biosciences, Inc. (AKYA)
USD 1.03
(-11.97%)
USD 1.03
(-11.97%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 17.87 Million USD | 23.41% |
| 2022 | 14.48 Million USD | 60.71% |
| 2021 | 9.01 Million USD | 111.45% |
| 2020 | 4.26 Million USD | 4.15% |
| 2019 | 4.09 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 22.98 Million USD | 28.59% |
| 2024 Q2 | 24.79 Million USD | 7.86% |
| 2023 Q1 | 14.5 Million USD | 0.14% |
| 2023 FY | 17.87 Million USD | 23.41% |
| 2023 Q3 | 18.75 Million USD | 16.25% |
| 2023 Q2 | 16.13 Million USD | 11.19% |
| 2023 Q4 | 17.87 Million USD | -4.67% |
| 2022 Q2 | 13.21 Million USD | 16.22% |
| 2022 Q1 | 11.37 Million USD | 26.17% |
| 2022 Q4 | 14.48 Million USD | 10.89% |
| 2022 FY | 14.48 Million USD | 60.71% |
| 2022 Q3 | 13.06 Million USD | -1.17% |
| 2021 Q4 | 9.01 Million USD | 47.94% |
| 2021 Q2 | 6.56 Million USD | 39.08% |
| 2021 Q1 | 4.71 Million USD | 10.67% |
| 2021 FY | 9.01 Million USD | 111.45% |
| 2021 Q3 | 6.09 Million USD | -7.15% |
| 2020 Q4 | 4.26 Million USD | 0.0% |
| 2020 FY | 4.26 Million USD | 4.15% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 4.09 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AngioDynamics, Inc. | 60.61 Million USD | 70.508% |
| AtriCure, Inc. | 67.89 Million USD | 73.67% |
| Avinger, Inc. | 5.29 Million USD | -237.429% |
| Azenta, Inc. | 128.19 Million USD | 86.055% |
| BioLife Solutions, Inc. | 43.45 Million USD | 58.862% |
| The Cooper Companies, Inc. | 735.6 Million USD | 97.57% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -254.0% |
| Femasys Inc. | 667.11 Thousand USD | -2579.736% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 27.67% |
| Hologic, Inc. | 679.8 Million USD | 97.37% |
| ICU Medical, Inc. | 709.36 Million USD | 97.48% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 98.535% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -413.515% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 65.84% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -1986.584% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -1986.584% |
| Masimo Corporation | 545 Million USD | 96.72% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -1005.412% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 94.117% |
| Nephros, Inc. | 2.47 Million USD | -623.765% |
| NovoCure Limited | 38.15 Million USD | 53.143% |
| NEXGEL, Inc. | 1.31 Million USD | -1255.345% |
| NEXGEL, Inc. | 1.31 Million USD | -1255.345% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -31.72% |
| OraSure Technologies, Inc. | 47.61 Million USD | 62.454% |
| Pro-Dex, Inc. | 15.26 Million USD | -17.08% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -3516.088% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -523.305% |
| QuidelOrtho Corporation | 577.8 Million USD | 96.906% |
| Repligen Corporation | 202.32 Million USD | 91.164% |
| Sanara MedTech Inc. | 4.71 Million USD | -278.948% |
| STAAR Surgical Company | 35.13 Million USD | 49.112% |
| Sharps Technology, Inc. | 1.7 Million USD | -945.968% |
| Utah Medical Products, Inc. | 9.58 Million USD | -86.569% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 97.135% |
| Jin Medical International Ltd. | 5.05 Million USD | -253.78% |